NICE’s new draft guideline for PTSD fails to mention how ICD-11 has profoundly shifted how we diagnose this disorder […]
Latest articles
Zackary Berger’s journal reviews—1 October 2018
Zackary Berger reviews the latest research from the top medical journals […]
Emma Cartwright and Jess Rees: The Cochrane Colloquium—a patient perspective
Emma Cartwright and Jess Rees received the Rosamund Snow award to attend the Cochrane Colloquium in Edinburgh The Cochrane Colloquium is a large international conference, which this year was held […]
Abraar Karan: Why we need more diversity in our doctors
The movement to change what a doctor looks like is a daily, incremental effort […]
Jeffrey Aronson: When I use a word . . . Medicine, medicines, and the Medicines Act 1968
As I pointed out last week, the IndoEuropean root MED, to measure or take appropriate measures, has given rise to a large number of English words, among them “medicine” and […]
Nick Hopkinson: Wellness, meaning, and control
“Being old enough to die is an achievement not a defeat, and the freedom it brings is worth celebrating.” From this striking vantage point, Barbara Ehrenreich, in her recent book […]
Kathryn Harrison: Social prescribing—let’s not leap in without the evidence
We need to provide patients and their GPs the time and space to build therapeutic relationships […]
Unreported clinical trial of the week: Gabapentin for cerebellar ataxia in degenerative and inflammatory CNS-disease (2008-005167-33)
Nick DeVito and Ben Goldacre Background The US FDA Amendments Act (FDAAA 2007) requires certain clinical trials to report their results onto ClinicalTrials.gov within one year of completion. European Union […]
Susan Jebb: Interventions to treat obesity work—so why am I not celebrating?
The evidence increasingly points to the system “failing” to offer people support for weight loss […]
Charging for maternity care: How did the “hostile environment” go this far?
Vulnerable women are bearing the brunt, say Neal Russell, Sophie Windsor, and Susan Bewley […]